18 December 2013 - Deborah Wilkes
Archived
Alliance Pharma has acquired all rights to Lypsyl in the UK and Ireland from Novartis for US$3.0 million.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.